Recently, the C-reactive protein–TyG index (CTI), which integrates insulin resistance and systemic inflammation, has been identified as a valuable predictor of cardiovascular disease, stroke risk, and liver fibrosis progression [16–18]. This evidence concerns the gene CRP and Insulin resistance.